Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

RECOVERY trial team win NIHR Impact Prize

RECOVERY trial finds that sotrovimab reduces the risk of death in some patients hospitalised with COVID-19

RECOVERY trial finds no significant benefit of molnupiravir or Paxlovid for patients hospitalised with COVID-19

Methylprednisolone and tocilizumab can reduce length of hospital stays for children with inflammation as a result of COVID-19

World-leading RECOVERY trial expands to investigate treatments for influenza

RECOVERY trial data included in a wider study that shows SGLT2 inhibitors are safe but not associated with improved survival in patients with COVID-19

RECOVERY trial to focus on sotrovimab and higher dose corticosteroids as potential treatments for severe COVID-19

Clinical Trials Day: How RECOVERY is leading the global fight against COVID

RECOVERY trial wins Prix Galien for Best Public Sector Innovation

RECOVERY trial finds that empagliflozin is not an effective treatment for patients hospitalised with COVID-19

RECOVERY trial finds that a higher dose of corticosteroids is harmful compared to usual care (which includes lower dose corticosteroids) in hospitalised COVID-19 patients who require only simple oxygen therapy

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

pregnant woman

How RECOVERY enabled participation of pregnant women in the search for COVID-19 treatments

RECOVERY trial team shortlisted for MRC Impact Prize

Hospital setting for COVID patients

RECOVERY trial finds that dimethyl fumarate does not improve recovery for patients hospitalised with COVID-19

Dr Leon Peto, Dr Mark Campbell and Dr Guilherme Pessoa-Amorim

RECOVERY trial celebrates two-year anniversary of life-saving dexamethasone result

RECOVERY Trial launched in India

Recruitment to higher dose corticosteroids closed for patients with hypoxia on no oxygen or receiving simple oxygen

Statement from the RECOVERY Chief Investigators

Paxlovid to be investigated by the RECOVERY Trial as a potential treatment for patients hospitalised with COVID-19

RECOVERY timeline

The RECOVERY Trial is two years old today

Load More